Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Rani Therapeutics Holdings, Inc. (RANI) had Normalized Pre-Tax Income of $-8.02M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.71M |
|
$-7.03M |
|
-- |
|
$1.71M |
|
$10.05M |
|
$-8.34M |
|
$0.32M |
|
$-8.02M |
|
|
Normalized Pre-Tax Income |
$-8.02M |
$-8.02M |
|
$-8.02M |
|
$-8.02M |
|
$-8.02M |
|
$-8.34M |
|
$-8.42M |
|
180.00M |
|
180.00M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$47.09M |
|
$0.60M |
|
$4.79M |
|
$51.88M |
|
$13.86M |
|
-- |
|
$2.48M |
|
$16.34M |
|
$35.54M |
|
$35.54M |
|
$35.54M |
|
123.78M |
|
| Cash Flow Statement Financials | |
$-6.50M |
|
$-2.45M |
|
$-0.03M |
|
$18.82M |
|
$9.84M |
|
$-8.97M |
|
$2.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-488.23% |
|
-488.23% |
|
-- |
|
-469.26% |
|
-411.77% |
|
$-6.51M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.84 |
|
107.60 |
|
-22.55% |
|
-22.55% |
|
-15.45% |
|
-22.55% |
|
$0.29 |
|
$-0.04 |
|
$-0.04 |
|